deltatrials
Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT07459946

Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence

Research on New Diagnosis and Treatment Technologies for Major Traditional Chinese Medicine Advantage Diseases - Multi-Omics and Artificial Intelligence-Driven Innovative TCM Diagnosis and Treatment Technologies for Diabetic Nephropathy

Sponsor: Jiazhen Yin

Updated 1 time since 2026 Last updated: Mar 4, 2026 Started: Mar 12, 2026 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07459946, this NA trial focuses on Chronic Renal Failure/ Kidney Disease and Diabetic Nephropathy Type 2 and remains actively recruiting participants. Sponsored by Jiazhen Yin, it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Mar 2026 – present · 4 months · monthly snapshotNot Yet Recruiting

Change History

1 version recorded
Not Yet Recruiting — NA [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jiazhen Yin
Data source: Hangzhou Hospital of Traditional Chinese Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.